FZABX
Price
$30.59
Change
-$0.45 (-1.45%)
Updated
Nov 18 closing price
Net Assets
1.63B
RERAX
Price
$59.61
Change
-$0.82 (-1.36%)
Updated
Nov 18 closing price
Net Assets
134.2B
Interact to see
Advertisement

FZABX vs RERAX

Header iconFZABX vs RERAX Comparison
Open Charts FZABX vs RERAXBanner chart's image
Fidelity Advisor Diversified Intl Z
Price$30.59
Change-$0.45 (-1.45%)
VolumeN/A
Net Assets1.63B
American Funds EUPAC R1
Price$59.61
Change-$0.82 (-1.36%)
VolumeN/A
Net Assets134.2B
FZABX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
FZABX vs. RERAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZABX is a Hold and RERAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 134B vs. FZABX (1.63B). FZABX pays higher dividends than RERAX: FZABX (1.56) vs RERAX (0.22). FZABX was incepted earlier than RERAX: FZABX (12 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than FZABX (0.73). FZABX is a more actively managed with annual turnover of: 37.00 vs. RERAX (35.00). FZABX has a lower initial minimum investment than RERAX: FZABX (0) vs RERAX (250). FZABX annual gain was more profitable for investors over the last year : 15.57 vs. RERAX (12.09). FZABX return over 5 years is better than : 17.30 vs. RERAX (0.50).
FZABXRERAXFZABX / RERAX
Total Expense Ratio0.731.5746%
Annual Report Gross Expense Ratio0.731.5746%
Fund Existence12 years23 years-
Gain YTD22.63918.203124%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.63B134B1%
Annual Yield % from dividends1.560.22725%
Returns for 1 year15.5712.09129%
Returns for 3 years39.8428.84138%
Returns for 5 years17.300.503,436%
Returns for 10 years60.8032.26188%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NROM0.200.01
+4.17%
Noble Roman's, Inc.
CWSRF14.570.35
+2.46%
Chartwell Retirement Residences
BPMUF59.29N/A
N/A
Basilea Pharmaceutica AG
BBXIB5.50N/A
N/A
BBX Capital, Inc.
PRNDY18.31-0.51
-2.71%
Pernod Ricard S.A.